Glaxo, Novartis drug combo delays breast cancer

[News]

Combining GlaxoSmithKline's Tykerb drug with Novartis's Femara candelay significantly the progression of breast cancer in some women,researchers said on Thursday.

More... (http://www.healthcentral.com/breast-cancer/news-278146-66.html)